
Federal judge reverses rule that would have removed medical debt from credit reports
The three national credit reporting agencies — Experian, Equifax, and TransUnion — announced last year that they would remove medical collections under $500 from U.S. consumer credit reports. The CFPB's rule was projected to ban all outstanding medical bills from appearing on credit reports and prohibit lenders from using the information.
Get Starting Point
A guide through the most important stories of the morning, delivered Monday through Friday.
Enter Email
Sign Up
The CFPB estimated the rule would have removed $49 million in medical debt from the credit reports of 15 million Americans. According to the agency, one in five Americans has at least one medical debt collection account on their credit reports, and over half of the collection entries on credit reports are for medical debts. The problem disproportionately affects people of color, the CFPB has found: 28 percent of Black people and 22 percent of Latino people in the US carry medical debt versus 17 percent of white people.
Advertisement
The CFPB was established by Congress after the 2008 financial crisis to monitor credit card companies, mortgage providers, debt collectors and other segments of the consumer finance industry. Earlier this year, the Trump administration requested that the agency halt nearly all its operations, effectively shutting it down.

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
39 minutes ago
- Yahoo
Hims (HIMS) Jumps 8.6% as Firm Still Open to Work With Novo
We recently published . Hims & Hers Health, Inc. (NYSE:HIMS) is one of Monday's top performers. Hims & Hers bounced back by 8.64 percent on Monday to close at $52.03 following announcements that it remains open to working with Novo Nordisk in the future despite the termination of its earlier partnership. Novo Nordisk, maker of blockbuster drugs Wegovy and Ozempic, terminated its deal with Hims & Hers Health, Inc. (NYSE:HIMS) in June over allegations that the latter failed to adhere to federal laws that prohibit mass sales of compounded drugs under the false guise of 'personalization.' Hims & Hers Health, Inc. (NYSE:HIMS) has been selling knockoff versions of the drugs for years amid strong demand, but was this year ordered by the Food and Drug Administration (FDA) to stop due to a now sufficient supply. A nurse in a telehealth platform talking with a patient on video call for consultation. After the termination, Hims & Hers Health, Inc. (NYSE:HIMS) CEO Andrew Dudum said he was upset that Novo Nordisk felt the pressure over the knockoff version, but said that there was 'no way in hell we're going to cave on that.' Based on its historical reporting dates, Hims & Hers Health, Inc. (NYSE:HIMS) will report its earnings results for the second quarter in the first week of August 2025. While we acknowledge the potential of HIMS as an investment, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and have limited downside risk. If you are looking for an extremely cheap AI stock that is also a major beneficiary of Trump tariffs and onshoring, see our free report on the . READ NEXT: 30 Stocks That Should Double in 3 Years and 11 Hidden AI Stocks to Buy Right Now. Disclosure: None. This article is originally published at Insider Monkey. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
5 hours ago
- Yahoo
How to Limit Medical Debt's Impact on Your Credit
Planning Medical expenses Credit - Getty Images For the millions of Americans struggling to pay off the costs of expensive medical procedures, the looming debt is accompanied by another threat: that the unpaid medical bills could drag down their credit scores, making it harder to get a credit card or buy a home or car. And now a rule that would have addressed that issue will no longer be going into effect. In the final days of President Joe Biden's term, the Consumer Financial Protection Bureau (CFPB) issued a rule that would have removed medical debt from credit reports. The goal was to 'reduce the burden of medical debt and ensure that patients are not denied access to credit for home mortgages, car loans, or small business loans due to unpaid medical bills,' according to the White House press release at the time. But under the Trump Administration, the CFPB flipped its stance on the rule, which had not yet gone into effect. And on Friday, a federal judge, who was appointed by President Donald Trump, vacated the rule, stating that it exceeded the CFPB's authority under the Fair Credit Reporting Act. Roughly $88 billion of unpaid medical bills are in collections across the U.S., according to the CFPB, which estimates that the issue affects about one in five Americans. JoAnn Volk, a research professor and co-director of the Center on Health Insurance Reforms at Georgetown University, says the judge's ruling 'eliminates an important protection for families who are going to be shut out of credit because of this medical debt that they could not avoid.' How medical debt impacts credit CFPB research has indicated that medical debt on credit reports is 'a poor predictor' of whether a person will repay a loan, but still 'contributes to thousands of denied applications on mortgages that consumers would be able to repay,' the agency said at the time the Biden-era rule was finalized. 'We know from prior studies that medical debt does not have meaningful predictive power for people's credit worthiness. Part of the reason is that medical debt, more than any other form of debt, is the result of bad luck, not bad financial behavior,' says Neale Mahoney, an economics professor at Stanford University and director of the Stanford Institute for Economic Policy Research. 'Nobody plans to go to the hospital or have a kid slip and fall and need to be rushed to the ER and have to pay those medical bills; that is just bad luck.' The Biden-era rule would have led to the approval of about 22,000 additional, affordable mortgages annually, and the credit scores of people with medical debt on their credit reports would increase by an average of 20 points, the CFPB estimated. Mahoney says vacating it will reduce credit access for people struggling with medical debt. There are some steps that can be taken to mitigate that impact—though they're limited. Financial assistance options Mahoney advises people who find themselves faced with burdensome medical bills to first take advantage of their hospital's or physician's financial assistance program. Many hospitals have such programs, which are often listed on the back of the bill, that can reduce or sometimes even eliminate the cost depending on a patient's income or assets. 'It can be a slog to work through the process, but for many people, addressing the issue with the hospital is better than letting that issue fester and then become a medical debt with a debt collector,' Mahoney says. There are some organizations, like Dollar For, that help patients navigate these financial assistance programs. The CFPB offers some general tips for people dealing with medical debt, such as confirming the unpaid bill with the appropriate source, contacting their insurer if they believe the service should have been covered, and disputing any errors in the bill or credit report. Debt payment plans If a person's debt has been sold to a debt collector and they're concerned about its potential impact on their credit score, Mahoney recommends that they try and negotiate a payment plan with the debt collection company. Sometimes, a debt collector may be open to receiving a payment that is more within reach for the patient and, in turn, removing that debt from the credit report, he says. Contact us at letters@
Yahoo
6 hours ago
- Yahoo
Trump says Coke agrees to use cane sugar in US
President Donald Trump said Wednesday beverage giant Coca-Cola has agreed to use cane sugar in its iconic drink in the U.S. "I have been speaking to Coca-Cola about using REAL Cane Sugar in Coke in the United States, and they have agreed to do so," Trump said in a post on his Truth Social platform. "I'd like to thank all of those in authority at Coca-Cola. This will be a very good move by them — You'll see. It's just better!" In a brief statement on its website, Coca-Cola said: "We appreciate President Trump's enthusiasm for our iconic Coca‑Cola brand. More details on new innovative offerings within our Coca‑Cola product range will be shared soon." High-fructose corn syrup has been Coca-Cola's primary sweetener in U.S. products since 1985. The company currently uses cane sugar in products sold in several other markets, including Mexico, the United Kingdom, Africa and the Middle East. The company also sells a limited amount of Coke in the U.S. made with sugar as a kosher option for Passover -- distinguished by its yellow caps, instead of red. A noted Diet Coke enthusiast, Trump's relationship with the beverage giant has been well-documented. Ahead of the inauguration for his second term, Trump received a special Presidential Commemorative Inaugural Diet Coke bottle from Coca-Cola Company Chairman and CEO James Quincey. Why the change? Trump didn't specify a reason for the change. However, the announcement comes as Robert F. Kennedy Jr.'s "Make America Healthy Again" initiative gains traction, which advocates for removing HFCS from American food products. The initiative cites research linking HFCS to various health issues that contributes to obesity and chronic illness. However, studies are mixed on whether cane sugar is healthier than HFCS, with research suggesting that any added sugars, regardless of what type, increase the risk of Type 2 diabetes and other diseases. Dietitians recommend limiting added sugars of all varieties to less than 50 grams per day for most adults. One 12-ounce can of Coke has roughly 39 grams of sugar. Coke's switch from sugar to corn syrup Coca-Cola's 1985 transition to high-fructose corn syrup in the United States was primarily a business decision, the company said. The change coincided with rising sugar prices and agricultural policies that made corn syrup a more economical alternative. Solve the daily Crossword